SEC Form 4 · accession 0001127602-16-035910
CVS HEALTH Corp · CVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne A. Finucane
Director
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000064803
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 25, 2015 | G | 600 | $93.90 | D | 16,719 | I | By Finucane Family Trust |
| Common StockF2 | Jan 4, 2016 | S | 2,000 | $95.8746 | D | 14,719 | I | By Finucane Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share CreditsF3 | $0.00 | holding | — | — | — | — | — | Common Stock | 2,629 | 2,629 | D |
Explanation of responses
- F1All sales were effected pursuant to a Rule 10b5-1 plan.
- F2Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $95.81 and $96.05 per share.
- F3Consists of deferred stock compensation payable pursuant to Reporting Person's election.